Advanced Search

    column
    Research Progress of CDK4/6 Inhibitor in Breast Cancer
    LIANG Min-ting, YANG Ci-qiu, WANG Kun
    2023, 23(2): 65-73. DOI: 10.12019/j.issn.1671-5144.2023.02.001
    Abstract FullText HTML PDF
    Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+/HER2-, Node-Positive, High-Risk, Early Breast Cancer: Review of monarchE Study
    XU Rui, HE Jia-fa, ZOU Jia-chen
    2023, 23(2): 74-77. DOI: 10.12019/j.issn.1671-5144.2023.02.002
    Abstract FullText HTML PDF
    MONALEESA-7 Study: Analysis of the Efficacy of Ribociclib Combined With Endocrine Therapy for Hormone Receptor Positive Premenopausal Advanced Breast Cancer
    YANG Mei, HUANG Shuai, SHU Mao
    2023, 23(2): 78-82. DOI: 10.12019/j.issn.1671-5144.2023.02.003
    Abstract FullText HTML PDF
    DAWNA-1 Study: Efficacy Analysis of Dalpiciclib Plus Fulvestrant in Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
    WANG Ying, ZHANG Xiao-qi
    2023, 23(2): 83-87. DOI: 10.12019/j.issn.1671-5144.2023.02.004
    Abstract FullText HTML PDF
    Ribociclib for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Luminal B Breast Cancer: CORALLEEN Study
    HU Hong, LIN Ying-yi
    2023, 23(2): 88-91. DOI: 10.12019/j.issn.1671-5144.2023.02.005
    Abstract FullText HTML PDF
    Randomized Phase Ⅱ RIGHT Choice Trial of Premenopausal Patients With Aggressive HR+/HER2- Advanced Breast Cancer Treated With Ribociclib and Endocrine Therapy
    XU Fei, LI Pei-yong
    2023, 23(2): 92-95. DOI: 10.12019/j.issn.1671-5144.2023.02.006
    Abstract FullText HTML PDF
    Diagnostic Value of Multimodal Magnetic Resonance Imaging in Glioma and Pathological Grading
    WANG Xin, WANG Ze-wei, LIN Ze-hui
    2023, 23(2): 96-102. DOI: 10.12019/j.issn.1671-5144.2023.02.007
    Abstract FullText HTML PDF
    Effects of Long Non-Coding RNA MALAT1 on the Transformation of Human Lung Fibroblasts Into Myofibroblasts
    CHANG Qing, CHEN Fei, ZHANG Tie-shuan, QIAO Hua, WAN Jun-ying
    2023, 23(2): 103-108. DOI: 10.12019/j.issn.1671-5144.2023.02.008
    Abstract FullText HTML PDF
    The High Expression of USP30 Promotes Carcinogenesis and Progression of Hepatocellular Carcinoma
    CHEN Xiu-yun, XIAO Bin, XUAN Jun-feng, CHEN Min, SUN Zhao-hui
    2023, 23(2): 109-118. DOI: 10.12019/j.issn.1671-5144.2023.02.009
    Abstract FullText HTML PDF
    Clinical Value of Immune Checkpoint Inhibitors in the Treatment of Advanced Lung Cancer
    LIU Si-yang Maggie, ZENG Kang-hui, JIE Guang-ling, WU Yi-long
    2023, 23(2): 119-124. DOI: 10.12019/j.issn.1671-5144.2023.02.010
    Abstract FullText HTML PDF
    When Clinical Trials Encounter the COVID-19 Epidemic
    XU Chong-rui, ZHOU Qing
    2023, 23(2): 125-128. DOI: 10.12019/j.issn.1671-5144.2023.02.011
    Abstract FullText HTML PDF